{"blog": [], "keywords": [{"value": "Boards of Directors", "name": "subject", "rank": "1", "is_major": "N"}, {"value": "Securities and Commodities Violations", "name": "subject", "rank": "2", "is_major": "N"}, {"value": "Schiller, Howard B", "name": "persons", "rank": "3", "is_major": "N"}, {"value": "Valeant Pharmaceuticals International Inc", "name": "organizations", "rank": "4", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/03/24/business/dealbook/valeant-has-few-options-to-remove-a-recalcitrant-director.html", "document_type": "article", "byline": {"person": [{"middlename": "Davidoff", "firstname": "Steven", "role": "reported", "rank": 1, "lastname": "SOLOMON", "organization": ""}], "original": "By STEVEN DAVIDOFF SOLOMON"}, "type_of_material": "News", "multimedia": [{"url": "images/2015/11/25/business/25DEALPROF/25DEALPROF-thumbWide.jpg", "legacy": {"wide": "images/2015/11/25/business/25DEALPROF/25DEALPROF-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2015/11/25/business/25DEALPROF/25DEALPROF-articleLarge.jpg", "legacy": {"xlarge": "images/2015/11/25/business/25DEALPROF/25DEALPROF-articleLarge.jpg", "xlargeheight": "600", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 600}, {"url": "images/2015/11/25/business/25DEALPROF/25DEALPROF-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/11/25/business/25DEALPROF/25DEALPROF-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Business Day", "word_count": "957", "source": "The New York Times", "subsection_name": "DealBook", "lead_paragraph": "Howard Schiller has been accused of improper conduct, but he refuses to leave quietly, and Valeant Pharmaceuticals is stuck.", "pub_date": "2016-03-24T00:00:00Z", "news_desk": "Business", "headline": {"kicker": "Deal Professor", "main": "Valeant Has Few Options to Remove a Recalcitrant Director", "content_kicker": "Deal Professor"}, "print_page": null, "snippet": "Howard Schiller has been accused of improper conduct, but he refuses to leave quietly, and Valeant Pharmaceuticals is stuck.", "_id": "56f2d94b38f0d870f33f89b6", "slideshow_credits": null, "abstract": null}